Picture of Treace Medical Concepts logo

TMCI Treace Medical Concepts Income Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousSmall CapSucker Stock

Annual income statement for Treace Medical Concepts, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
C2021
December 31st
C2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:PROSPECTUSPROSPECTUS10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue39.457.494.4142187
Cost of Revenue
Gross Profit31.844.977.5116152
Selling / General / Administrative Expenses
Research And Development
Unusual Expense / Income
Total Operating Expenses4356.5111181239
Operating Profit-3.540.855-16.5-39.6-51.4
Total Net Non Operating Interest Income / Expense
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes-4.26-3.67-20.6-42.8-49.5
Net Income After Taxes-4.26-3.67-20.6-42.8-49.5
Net Income Before Extraordinary Items
Net Income-4.26-3.67-20.6-42.8-49.5
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income-4.91-4.31-20.7-42.8-49.5
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS-0.097-0.085-0.429-0.688-0.814
Dividends per Share